Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use

Obes Surg. 2021 Aug;31(8):3848-3850. doi: 10.1007/s11695-021-05391-0. Epub 2021 Apr 24.

Authors

Erica A Amianda¹, Thomas S Gavigan², Toghrul Talishinskiy², Douglas R Ewing², Hans J Schmidt²

Affiliations

¹ Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA. erica.amianda@hmhn.org.
² Center for Bariatric Medicine and Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite 703, Hackensack, NJ, 07601, USA.

PMID: 33895974
DOI: 10.1007/s11695-021-05391-0

No abstract available

Publication types

Letter

MeSH terms

Bariatric Surgery* / adverse effects
Diabetes Mellitus, Type 2* / drug therapy
Diabetic Ketoacidosis* / chemically induced
Glucose
Humans
Obesity, Morbid* / surgery
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Sodium-Glucose Transporter 2 Inhibitors
Sodium
Glucose